论文部分内容阅读
目的进一步验证中药新制剂地榆升白片对白细胞下降患者的治疗作用。方法将110例化疗后白细胞下降的患者随机分为治疗组和对照组,治疗组口服地榆升白片,对照组口服利血生加鲨肝醇,观察两组疗效。结果两组药物对化疗所致白细胞下降的患者,均有升高作用,且其疗效相近(P>0.05);但在临床症状改善方面,差异有统计学意义(P<0.05)。结论地榆升白片对化疗所致白细胞下降患者,确有升高其白细胞的作用,其疗效与利血生和鲨肝醇相近,但在改善患者临床症状方面,其疗效则优于对照组。
Objective To further verify the therapeutic effect of Qishengbai Tablets, a new preparation of traditional Chinese medicine, on patients with leukopenia. Methods One hundred and ten patients with leukopenia after chemotherapy were randomly divided into treatment group and control group. The treatment group received intramuscular injection of white tablets. The control group was treated with Lixuesheng plus shark liver alcohol. The efficacy of the two groups was observed. Results The effects of both drugs on the patients with leukopenia caused by chemotherapy were all increased, and their efficacy was similar (P>0.05). However, there was a significant difference in clinical symptoms (P<0.05). Conclusion Diqishengbai Tablets can increase the leukocytes in patients with chemotherapy-induced leukopenia. The efficacy is similar to that of Lixuesheng and Shaheheol, but its efficacy is better than the control group in improving the clinical symptoms of patients. .